Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

NCT04129931 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT04129931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04129931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 2
Overall status
Completed
Start date
December 19, 2019
Completion date
March 19, 2025
Enrollment
950 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

asthma